Submit manuscript...
Journal of
eISSN: 2373-633X

Cancer Prevention & Current Research

Reviewers

 Anirudh Sethi

 Mohamed Eldeeb
University of Alberta, Canada
Research Interest: Protein Degradation, Ubiquitin-mediated protein regulation, cell death, apoptosis, anti-cancer chemotherapeutics, chronic myeloid leukemia, Prostate cancer, Phosphorylation, kinases, proteasome
 Supriya Sen
University of California Los Angeles, United States
Research Interest: Molecular Biology, Biochemistry, Cell Biology, Metabolism, RNA splicing, Liver disease, Hepatocellular Carcinoma, Diabetes, Signaling, Mouse Models, Genomics and Bioinformatics
 Aparna Lakshmanan
The Ohio State University, United States
Research Interest: I am passionate to learn from and to contribute to a team that works on clinical and translational cancer research
 Asfandyar Khan Niazi
University of Dundee, United Kingdom
Research Interest: Medical and Health Sciences Research
 Parash Parajuli
University of Mississippi Medical Center, United States
Research Interest: Cell and molecular biology, Enzyme Immunoassay, Anti-tumorigenic activity of small molecules/nanoparticles in mouse xenograft models
 Nidhi Guptha
Centrillion Technologies, United States
Research Interest: Immunocytochemistry, mmunofluorescence, multiple base extension assays for cancer genomic studies
  Joslin Dogbe
University of the Witwatersrand, Ghana
Research Interest: Cancer related disabilities in children
 Prabhsimranjot Singh
New York Presbyterian Hospital, United States
Research Interest: Hematology, Oncology
 Kalyan Pradhan
University of California, United States
Research Interest: Genome-wide analysis: ChIP-seq and RNA-seq, gene knockout and genome engineering by CRISPR/Cas, epigenetics, histone variants, in vito transcription, Immobilized Template assay (IT assay) for capturing pre-initiation complex, chromatin remodeling, protein expression and purification, spectroscopy
 Harshad Mahadeshwar
Texas Tech University, United States
Research Interest: Drug Target Discovery, Oncogenomics and Genomic Medicine
 Shubhamoy Ghosh
University of California, United States
Research Interest: Immunology, Biotechnology, Biotechnology
 Roelof Koster
National Cancer Institute at the National Institutes of Health, United States
Research Interest: Basic cancer research, Biology and life sciences, Cancer detection and diagnosis, Cancer genetics, Cancer prevention, Cancer risk factors, Cancer treatment, Epidemiology, Genetic screens, Genetics, Genetics of disease, Genitourinary cancers, Sarcoma, Genome sequencing, Genome-wide association studies, Genomic medicine, Genomics, Human genetics, Molecular genetics, Oncology
 Sumit Agarwal
University of Alabama at Birmingham, United States
Research Interest: Cancer Biomarker Discovery platform: Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries. Cancer immunotherapy has an edge over other classical treatment modalities in that it is less prone than conventional drugs to severe side effects. Early detection is the most important aspect of clinical cancer research because it directly improves the efficacy of treatment interventions and survival rate. Our lab focuses on identifying molecular alterations in cancers and the biology associated with them. I am also exploring the involvement of key tumor specific molecules in the complex cancer signaling networks. Although the association of these molecules in cellular proliferation, migration and invasion has been established but the precise mechanism which is involved is still unknown. Therefore I am trying to find out and understand the underlying molecular mechanisms involved in tumorigenic properties and behaviors of cancer cells
  Anantha Lakshmi Marisetty
University of Massachusetts, United States
Research Interest: tumorigenesis in glioblastoma stem cells, GBM immune suppression and activation
 Animesh Shukla
Meso Scale Diagnostics, LLC., Rockville, United States
Research Interest: Organize and manage Breast Cancer
 Arunima Purkayastha
University of California, United States
Research Interest: My research interest focuses on cancer biology specifically in the field of cellular- and metabolic-signaling, using Drosophila as a model system. As an Asst. Project Scientist I am studying the role of the glycolytic enzyme Aldolase in regulating RTK-induced overgrowth. Using RNA-seq, I have observed that Ald is one of the most upregulated glycolytic enzyme upon RTK-over activation. Interestingly, knocking down Ald in an RTK-overactivated background, but not other glycolytic enzymes, reduces over proliferation dramatically. I am currently investigating the molecular mechanism by which Ald rescues overgrowth
 Atanu Paul
University of Texas, United States
Research Interest: Biochemistry, Cell and Molecular Biology, Post-translational modifications, Epigenetics, DNA damage response and repair, Cancer and metastasis
 Soumyajit Banerjee Mustafi
University of Oklahoma, United States
Research Interest: Molecular Biology, cell biology tissue culture embryonic stem cells, tumor cells, generating and maintaining transgenic mouse lines
 Tina Cc Chang
The University of Texas MD Anderson Cancer Center, United States
Research Interest: ER negative breast cancer, cancer research
 Dan Li
Rutgers University, United States
Research Interest: I was involved in two independent research projects, one in the field of prostate cancer (under Dr. Lizhao Wu) and the other in the field of chronic myelogenous leukemia (CML) (under Dr. Ian Whitehead). Both of these projects were focused on the use of murine models of disease. In the prostate cancer project, I used a genetically modified mouse model of prostate cancer to study the role of the Myc/E2F pathway during prostate cancer development. E2F3 is an important downstream effector of the Myc oncogene that controls cell cycle, proliferation and apoptosis. The other project was focused on exploring the role of XPB binding in p210 BCR/ABL-induced CML. Using a bone marrow transplantation mouse model, we found that XPB binding was important for regulating RhoGEF activity of p210 BCR/ABL, as well as Myc expression, which contributes to leukemogenesis. Upon graduating, I joined the lab of Dr. Betsy Barnes as a postdoctoral fellow to study the role of interferon regulatory factor 5 (IRF5) in mammary tumorigenesis.
 Eric Lee
Fox Chase Cancer Center, Philadelphia, United States
Research Interest: stem cell, Genetic and epigenetic factors, Cancer Biology
 Hooman Parsi

 Manish Tandon

 Naga Rama Kothapalli

 Su Song

 Maisha Standifer

 Veerendra Koppolu
University of Kansas , United States
Research Interest: Pre-clinical and clinical development of monoclonal antibodies and novel small molecules as breakthrough therapies for cancer and infectious diseases. Characterization and Potency evaluation of drugs and vaccines
 Ahmad Monzer Maaliki

 Vladimir N Pak

 Sushila Ladumor

 Humera Mahmood

 Priyanka

 Ahmed Mohammed Morsy

 Piyush Vyas
Senior Consultant Oncologist, Poland
Research Interest: Hepatocellular cancer, Pancreatic cancer, Immune thrombocytopenia, Colorectal Cancer, Lung Adenocarcinomas. Solid tumors, Hematooncology
 Rub Nawaz Baloch
Jinnah Postgraduate Medical Center, Pakistan
Research Interest: Radiation Oncology and Molecular Imaging
 Irfan Majid Lone

 Xiaojing Dai

 Xiaojing Dai